Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
Presented a poster highlighting the use of the Company’s Magellan™ drug discovery platform to identify allosteric inhibitors targeting discoidin domain receptor 2 at the 36 th EORTC-NCI-AACR Symposium ...
US firm Vishay Intertechnology confirms £250m investment at UK's biggest semiconductor facility
The £250m investment is being supported by the UK Government as part of long-term plans by Vishay to invest £1bn and create ...
For Construction Pros15h
Tadano Brings New Line of MEWP Series
Built on the legacy of its cranes, Tadano has launched a mobile elevating work platform series of articulated and telescopic ...
Prime city centre hotel to be taken over by Newcastle City Council in lieu of loans, accounts reveal
Clouston Group built and opened the Crowne Plaza Hotel in Newcastle 10 years ago but it is now poised to be handed over to ...
Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas
SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft ...